At the time of writing, over 332 million people across the globe have contracted COVID-19, and the death toll from the virus sits at just over 5.5 million. Many people who have had COVID-19 and recovered from it are still dealing with the aftermath of the infection. Lasting symptoms and other health complications have begun developing in many people – so many that the phenomenon has earned the name “long COVID” or “post-COVID-19 syndrome”.
The typical symptoms of a COVID-19 infection can linger for months after the infection has cleared in many people, and in some cases, the infection has led to organ damage, blood clots and blood vessel issues, mood and fatigue disorders, and even a condition known as Guillain-Barre syndrome that causes temporary paralysis. With so many ailments and conditions arising after a COVID-19 infection, new research is investigating whether the reactivation of the Epstein-Barr virus (EBV) could also be added to the list. Read on for more information about reactivation of EBV after COVID.Continue reading “Could EBV Reactivation Help Explain The Prevalence Of Long COVID?”